Candel Therapeutics, Inc. SEC filings CADL
Candel Therapeutics, Inc. has 418 filings in SEC EDGAR's recent list, going back to Feb 16, 2021. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 10, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 5, 2026 | Nov 3, 2026 |
| 3 | Initial insider ownership | Nov 5, 2026 | Nov 3, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Sep 11, 2026 | Sep 10, 2026 |
| 144 | Notice of proposed sale | Sep 10, 2026 | — |
| 4 | Insider transaction | Sep 10, 2026 | Sep 8, 2026 |
| 3 | Initial insider ownership | Sep 10, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 10, 2026 | Sep 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2026 | Sep 9, 2026 |
| 4 | Insider transaction | Aug 19, 2026 | Aug 17, 2026 |
| 144 | Notice of proposed sale | Aug 17, 2026 | — |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 27, 2026 | — |
| 4 | Insider transaction | Jul 8, 2026 | Jul 6, 2026 |
| 3 | Initial insider ownership | Jul 8, 2026 | Jul 6, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 30, 2026 |
| 144 | Notice of proposed sale | Jun 29, 2026 | — |
| 144 | Notice of proposed sale | Jun 29, 2026 | — |
| 4 | Insider transaction | Jun 24, 2026 | Jun 23, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 23, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 23, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 23, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 23, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 23, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 23, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 23, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 23, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2026 | Jun 23, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 16, 2026 | Jun 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 15, 2026 | May 15, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Jun 23, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 27, 2026 | — |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 18, 2026 | — |
| S-8 | Employee stock plan registration | Mar 12, 2026 | — |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2026 | Mar 12, 2026 |
| 4 | Insider transaction | Feb 26, 2026 | Feb 23, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 23, 2026 | Feb 19, 2026 |
| 424B5 | Prospectus supplement | Feb 20, 2026 | — |
| 424B5 | Prospectus supplement | Feb 19, 2026 | — |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure, Other events
|
Feb 19, 2026 | Feb 19, 2026 |
| 4 | Insider transaction | Jan 28, 2026 | Jan 26, 2026 |
| 4 | Insider transaction | Jan 28, 2026 | Jan 26, 2026 |
| 4 | Insider transaction | Jan 28, 2026 | Jan 26, 2026 |
| 4 | Insider transaction | Jan 28, 2026 | Jan 26, 2026 |
| 4 | Insider transaction | Jan 28, 2026 | Jan 26, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 21, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 5, 2025 | Dec 5, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Material agreement, Results of operations, New debt, Unregistered share sale, Regulation FD disclosure, Other events
|
Oct 14, 2025 | Oct 14, 2025 |
| EFFECT | Filing | Aug 22, 2025 | — |
| 8-K |
Current report
Material agreement
|
Aug 21, 2025 | Aug 18, 2025 |
| CORRESP | Letter to the SEC | Aug 20, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 20, 2025 | — |
| S-3 | Shelf registration | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 4 | Insider transaction | Jul 30, 2025 | Jul 28, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 144 | Notice of proposed sale | Jun 30, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 30, 2025 | — |
| 4 | Insider transaction | Jun 26, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 24, 2025 | Jun 20, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 24, 2025 | Jun 23, 2025 |
| 424B5 | Prospectus supplement | Jun 24, 2025 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 23, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 17, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 17, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 17, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 17, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 17, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 17, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 17, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2025 | Jun 17, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 4, 2025 |
| 3 | Initial insider ownership | Jun 6, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 6, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 28, 2025 | May 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 22, 2025 | May 22, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 23, 2025 | Apr 23, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 27, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 20, 2025 | Mar 18, 2025 |
| 4 | Insider transaction | Mar 20, 2025 | Mar 18, 2025 |
| 4 | Insider transaction | Mar 20, 2025 | Mar 18, 2025 |
| 4/A | Filing | Mar 20, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 19, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 19, 2025 | Mar 17, 2025 |
| 144 | Notice of proposed sale | Mar 18, 2025 | — |
| 144 | Notice of proposed sale | Mar 18, 2025 | — |
| 144 | Notice of proposed sale | Mar 18, 2025 | — |
| 144 | Notice of proposed sale | Mar 17, 2025 | — |
| 144 | Notice of proposed sale | Mar 17, 2025 | — |
| S-8 | Employee stock plan registration | Mar 13, 2025 | — |
| 10-K | Annual report | Mar 13, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2025 | Mar 13, 2025 |
| 4 | Insider transaction | Feb 25, 2025 | Feb 21, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 25, 2025 | Feb 25, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 4 | Insider transaction | Feb 14, 2025 | Feb 12, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 12, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 12, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 12, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 12, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| 4 | Insider transaction | Feb 13, 2025 | Feb 10, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 7, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 7, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 7, 2025 | — |
| 4 | Insider transaction | Jan 17, 2025 | Jan 15, 2025 |
| 4 | Insider transaction | Jan 17, 2025 | Jan 15, 2025 |
| 4 | Insider transaction | Jan 17, 2025 | Jan 15, 2025 |
| 4 | Insider transaction | Jan 17, 2025 | Jan 15, 2025 |
| 4 | Insider transaction | Jan 17, 2025 | Jan 15, 2025 |
| 144 | Notice of proposed sale | Jan 15, 2025 | — |
| 144 | Notice of proposed sale | Jan 15, 2025 | — |
| 144 | Notice of proposed sale | Jan 15, 2025 | — |
| 144 | Notice of proposed sale | Jan 15, 2025 | — |
| 144 | Notice of proposed sale | Jan 15, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 13, 2025 | Jan 13, 2025 |
| 4 | Insider transaction | Jan 10, 2025 | Jan 8, 2025 |
| 4 | Insider transaction | Jan 10, 2025 | Jan 8, 2025 |
| 4 | Insider transaction | Jan 10, 2025 | Jan 8, 2025 |
| 4 | Insider transaction | Jan 10, 2025 | Jan 8, 2025 |
| 4 | Insider transaction | Jan 10, 2025 | Jan 8, 2025 |
| 144 | Notice of proposed sale | Jan 8, 2025 | — |
| 144 | Notice of proposed sale | Jan 8, 2025 | — |
| 144 | Notice of proposed sale | Jan 8, 2025 | — |
| 144 | Notice of proposed sale | Jan 8, 2025 | — |
| 144 | Notice of proposed sale | Jan 8, 2025 | — |
| 4 | Insider transaction | Dec 30, 2024 | Dec 26, 2024 |
| 4 | Insider transaction | Dec 26, 2024 | Dec 20, 2024 |
| 4 | Insider transaction | Dec 18, 2024 | Dec 16, 2024 |
| SC 13G | Ownership over 5% (passive) | Dec 17, 2024 | — |
| 4 | Insider transaction | Dec 13, 2024 | Dec 11, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 13, 2024 | Dec 12, 2024 |
| 424B5 | Prospectus supplement | Dec 13, 2024 | — |
| 424B5 | Prospectus supplement | Dec 12, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 11, 2024 | Dec 11, 2024 |
| 4 | Insider transaction | Dec 6, 2024 | Dec 4, 2024 |
| 4 | Insider transaction | Dec 3, 2024 | Nov 29, 2024 |
| 4 | Insider transaction | Dec 3, 2024 | Nov 29, 2024 |
| 4 | Insider transaction | Dec 3, 2024 | Nov 29, 2024 |
| 4 | Insider transaction | Dec 3, 2024 | Nov 29, 2024 |
| 144 | Notice of proposed sale | Nov 29, 2024 | — |
| 144 | Notice of proposed sale | Nov 29, 2024 | — |
| 144 | Notice of proposed sale | Nov 29, 2024 | — |
| 144 | Notice of proposed sale | Nov 29, 2024 | — |
| 4 | Insider transaction | Nov 27, 2024 | Nov 25, 2024 |
| 4 | Insider transaction | Nov 21, 2024 | Nov 21, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 4 | Insider transaction | Nov 8, 2024 | Nov 6, 2024 |
| 4 | Insider transaction | Nov 1, 2024 | Oct 30, 2024 |
| 4 | Insider transaction | Oct 28, 2024 | Oct 24, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 28, 2024 | Oct 28, 2024 |
| 4 | Insider transaction | Oct 15, 2024 | Oct 11, 2024 |
| 4 | Insider transaction | Oct 3, 2024 | Oct 1, 2024 |
| 144 | Notice of proposed sale | Sep 23, 2024 | — |
| 144 | Notice of proposed sale | Sep 13, 2024 | — |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 4 | Insider transaction | Jul 19, 2024 | Jul 17, 2024 |
| 4 | Insider transaction | Jul 19, 2024 | Jul 17, 2024 |
| 4 | Insider transaction | Jul 19, 2024 | Jul 17, 2024 |
| 4 | Insider transaction | Jul 19, 2024 | Jul 17, 2024 |
| 4 | Insider transaction | Jul 19, 2024 | Jul 17, 2024 |
| 144 | Notice of proposed sale | Jul 17, 2024 | — |
| 144 | Notice of proposed sale | Jul 17, 2024 | — |
| 144 | Notice of proposed sale | Jul 17, 2024 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CADL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Needham, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1841387
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.